The overall goal of Penwest’s product development portfolio is to build a strong pipeline of products in which drug delivery can improve compliance and offer clinical benefits. Our current product pipeline is a combination of partnered development programs, our own internal pharmaceutical development programs, and products that are enhanced versions of existing drugs available for out-licensing.

Product selection and portfolio management are critical components of the Company’s success. Penwest’s flexible strategy for building a product portfolio balances opportunity and risk to create long-term financial value and strengthen our position in the marketplace.